Maganin Cigaban Ciwon Kankara

"Muna haɗa masu fama da ciwon daji na ci gaba zuwa ci gaba da hanyoyin kwantar da hankali da gwajin asibiti."

Muna aiki tare da saman
asibitocin ciwon daji a duniya

"Maganin ciwon daji na ci gaba tare da yanke-yanke
CAR T-Cell far, Til far, da gwaji na asibiti.
Ku kasance tare da mu don yaƙar kansa a yau!"

"Ta hanyar sababbin hanyoyin warwarewa da sadaukarwa maras tabbas, muna ƙoƙari don kawar da shinge, samar da bege, da kuma
ba da gudummawa ga duniyar da ciwon daji ba kawai magani ba ne amma ana iya yin nasara."

Babban maganin ciwon daji

CAR T-cell Far, gwaji na asibiti
Da Magani A Waje

1.

Magungunan Kwayoyin Halitta

CancerFax wani dandali ne na majagaba wanda aka keɓe don haɗa mutane da ke fuskantar ciwon daji na zamani tare da hanyoyin kwantar da hankulan ƙwayoyin cuta kamar CAR T-Cell far, Til far, da gwaji na asibiti a duk duniya. Wannan sabis na ceton rai yana ba wa marasa lafiya damar bincika sabbin iyakoki a cikin maganin cutar kansa yayin ba su cikakkun bayanai game da ƙa'idodin cancantar gwaji, wurare, da hanyoyin yin rajista.

2.

Magani A Waje

CancerFax shine mafi amintaccen mai gudanarwa na masu haƙuri na ƙasa da ƙasa, yana aiki tare da manyan asibitocin cutar kansa a duniya kamar MD Anderson, Dana Farber, Mayo Clinic, Parkway Singapore, Asan, Sheba, NCC Japan, Cibiyar Ciwon daji ta Beijing, Apollo, da BLK Max don kawo muku. sabbin magunguna da hanyoyin kwantar da hankali. Ƙungiyarmu tana tabbatar da marasa lafiya sun sami sabis na concierge don maganin ciwon daji a cikin Amurka, Japan, Koriya ta Kudu, Isra'ila, China, da Indiya.

Babban mataki maganin cutar kansar huhu

3.

gwajinsu

Kamfaninmu ya ƙware a sabis na gwaji na asibiti na ciwon daji, yana ba da damar samun damar yin bincike mai zurfi da zaɓuɓɓukan magani. Mun haɗu da marasa lafiya tare da gwaje-gwaje masu mahimmanci, ƙarfafa bege da ci gaba a cikin yaki da ciwon daji. Tare da alƙawarin inganta rayuwa, muna kan gaba wajen haɓaka kula da cutar kansa ta hanyar ƙirƙira na asibiti.

Gwajin gwaji

CancerFax ya ƙware wajen jagorantar mutane ta hanyar hadadden tsari na yin rajista a cikin gwajin asibiti na ciwon daji. Tare da sadaukar da kai ba tare da katsewa ba, muna haɗa marasa lafiya zuwa bincike mai zurfi da zaɓuɓɓukan magani, suna ba da bege na rayuwa a yaƙin da suke yi da kansa. Ƙwararrun ƙwararrun ƙwararrun jinƙai suna zagaya cikin ƙaƙƙarfan duniyar gwaji na asibiti, suna tabbatar da cewa kowane majiyyaci ya sami goyan baya da jagora na keɓaɓɓen. Mun himmatu wajen ƙarfafa majiyyata, ba su damar samun sabbin hanyoyin warkewa, da haɓaka yaƙi da cutar kansa. A kamfaninmu, mun yi imanin cewa shiga cikin gwaji na asibiti na iya zama muhimmin mataki zuwa kyakkyawar makoma.

Duba cikakkun bayanai

CAR T-Cell Far

CAR T Ciwon ƙwayar cuta tsarin rigakafi ne na juyi na juyi wanda ke ba da sabon bege a cikin yaƙi da cutar kansa. CAR, wanda ke nufin Chimeric Antigen Receptor, mai karɓa ne na roba wanda aka ƙera shi cikin ƙwayoyin T na majiyyaci, kariya ta halitta daga cututtuka. Waɗannan ƙwayoyin CAR T da aka gyara an ƙera su don ganewa da kai hari kan takamaiman ƙwayoyin cutar kansa tare da daidaito, suna kiyaye kyallen kyallen takarda. Magungunan ƙwayoyin cuta na CAR T sun nuna nasara mai ban mamaki, musamman wajen magance wasu nau'in cutar sankarar bargo da lymphoma, wanda ke haifar da remission da inganta yanayin rayuwa a wasu lokuta. Duk da kalubale irin su illar illa da tsadar kaya, binciken da ake ci gaba da yi na nufin fadada aikace-aikacensa zuwa ga manyan cututtukan daji, yana mai yin alkawarin samun kyakkyawar makoma a yakin da ake yi da wannan muguwar cuta.

Duba cikakkun bayanai

Maganin ciwon daji a Amurka

A cikin {asar Amirka, kula da ciwon daji wani kyakkyawan tsari ne na kirkire-kirkire, bincike, da kulawa mai iyaka. Manyan asibitocin ciwon daji a Amurka yi amfani da fasahar yankan-baki kamar immunotherapy da ingantacciyar magani don keɓance hanyoyin kwantar da hankali ga ƙayyadaddun kwayoyin halittar kowane majiyyaci da nau'in ciwon daji. Wannan dabarar da aka keɓance ta haifar da sakamako mai kyau da ƙarancin tasiri. Hakanan ana samun sauƙin gwaji na asibiti, yana ba marasa lafiya damar samun sabbin jiyya waɗanda ke nuna alƙawarin nan gaba. Duk da haka, yawan kuɗin da ake kashewa na maganin ciwon daji yana ci gaba da zama matsala, yana haifar da ci gaba da tattaunawa game da samun dama da kuma araha na kiwon lafiya. Masu fama da cutar daji da iyalansu na ci gaba da samun bege saboda sadaukarwar da Amurka ta yi na karya sabuwar hanyar maganin cutar kansa.

Duba cikakkun bayanai

Maganin ciwon daji a Indiya

Maganin ciwon daji a Indiya ya sami ci gaba mai mahimmanci, yana ba da ci gaba na hanyoyin kwantar da hankali kamar tiyata, chemotherapy, radiation, da immunotherapy. Manyan asibitocin ciwon daji a Indiya kamar Tata Memorial Center, Apollo Cancer Hospital, BLK, Artemis, Asian Oncology, American Oncology, HCG, da dai sauransu, suna ba da kulawa ta duniya. Amfanin Indiya ya ta'allaka ne ga samun araha, yana jan hankalin masu yawon bude ido na likita da ke neman ingantattun magunguna masu tsadar gaske.

Duba cikakkun bayanai

Maganin ciwon daji a Singapore

Maganin ciwon daji a cikin Singapore yana da alaƙa da fasahar likitanci mai yanke shawara da cikakkiyar hanyar kulawa. Wurare masu daraja na duniya kamar Cibiyar Ciwon daji ta Parkway suna ba da ɗimbin jiyya, daga tiyata da chemotherapy zuwa hanyoyin kwantar da hankali da rigakafi. Ƙungiyoyin ƙwararrun ƙwararrun likitocin ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwararrun ƙwanƙwasa suna tsara tsare-tsaren jiyya na musamman, suna tabbatar da kyakkyawan sakamako ga marasa lafiya. An san tsarin kula da lafiyar Singapore don inganci da samun dama, yana jan hankalin marasa lafiya daga ko'ina cikin duniya. Bayan kulawar likita, ƙasar tana ba da yanayin tallafi ga marasa lafiya da danginsu, tare da ƙungiyoyin tallafi da yawa da sabis na ba da shawara don taimakawa tafiyar ƙalubale na maganin cutar kansa.

Duba cikakkun bayanai

Maganin ciwon daji a Koriya ta Kudu

Maganin ciwon daji a Koriya ta Kudu yana da alaƙa da haɗin kai na al'ada da hanyoyin zamani na kiwon lafiya. Manyan cibiyoyin kiwon lafiya kamar Cibiyar Ciwon daji ta Koriya da Cibiyar Kiwon Lafiya ta Asan suna ba da fasaha ta zamani da cikakkiyar tsarin kula da haƙuri. Tsarin kiwon lafiya na Koriya ta Kudu ya shahara saboda ingancinsa, samun damarsa, da ingancin kulawa, yana jan hankalin marasa lafiya daga ko'ina cikin duniya. Ƙasar tana alfahari da ingantacciyar masana'antar yawon shakatawa ta likitanci, tana ba da ingantattun jiyya kamar ingantattun magunguna da rigakafi. Marasa lafiya suna amfana ba kawai daga manyan hanyoyin kwantar da hankali ba har ma daga tsarin muhalli mai tallafawa na bincike, gwaji na asibiti, da cikakkiyar sabis na kula da cutar kansa.

Ciwon daji a Isra'ila

Maganin ciwon daji a Isra'ila yana kan gaba a cikin sabbin hanyoyin kiwon lafiya. Shahararriyar bincikenta na ci gaba da hanyoyin kwantar da hankali na majagaba, tsarin kula da lafiyar Isra'ila yana ba da kulawar cututtukan daji na duniya. Manyan cibiyoyi kamar Cibiyar Kiwon Lafiya ta Sheba da Asibitin Hadassah suna yin amfani da fasahar zamani, ingantaccen magani, da rigakafi don magance cutar kansa yadda ya kamata. Yanayin haɗin gwiwa na Isra'ila yana ƙarfafa bincike mai zurfi da gwaji na asibiti, yana mai da ta zama cibiyar ƙididdigewa a cikin ilimin cututtukan daji. Bugu da ƙari, tsarin jinƙai da nau'i-nau'i daban-daban yana tabbatar da cikakkiyar kulawar marasa lafiya, yayin da masu yawon shakatawa na likita ke neman gwaninta. Yunkurin Isra'ila game da maganin cutar kansa ya wuce iyaka, yana ba da bege da ci gaba da mafita ga marasa lafiya a duk duniya.

CAR T-Cell far a Indiya

Sabuwar fasahar CAR-T ta Indiya, NexCAR19, ita ce dabarar farko ta 'yan asalin ƙasar don yaƙar kansa. ImmunoACT, reshe na IIT Bombay ne ya ƙirƙira, wannan ci-gaban jiyya na amfani da ƙwayoyin halittar T-cell da aka gyara don yin niyya da kawar da ƙwayoyin cuta, musamman a cikin cututtukan jini kamar cutar sankarar bargo da lymphomas. Gwaji na farko sun nuna yuwuwar, tare da kusan kashi 50 cikin dari suna samun cikakkiyar gafara, musamman a cikin yara kanana na cutar sankarar lymphoblastic mai girma B-cell. NexCAR19 yana nuna raguwar neurotoxicity idan aka kwatanta da zaɓuɓɓukan waje, yana nuna yuwuwar fa'ida akan jiyya na yanzu. Indiya tana shirin ba da wannan magani a cikin rahusa idan aka kwatanta da farashin duniya, farawa a kusan INR 30-40 lakhs da nufin rage shi zuwa INR 10-20 lakhs tare da amincewar tsari.

Duba cikakkun bayanai

CAR T-Cell far a China

CAR T-cell far a kasar Sin ya sami ci gaba na ban mamaki a cikin 'yan shekarun nan, wanda ke nuna ci gaban duniya a cikin wannan babban maganin cutar kansa. Tare da gwaje-gwajen asibiti sama da 700 da ke gudana, kasar Sin ta jagoranci ci gaban fasahar CAR T-Cell. Kasar Sin ta amince da maganin CAR T-cell cikin sauri, tana ba da sabon fata ga marasa lafiya da ke fama da cututtukan daji daban-daban, ciki har da cutar sankarar bargo da lymphoma. Yawancin asibitocin kasar Sin da cibiyoyin bincike suna gudanar da gwaje-gwaje na asibiti da gaske tare da ba da maganin CAR T-cell ga marasa lafiya da suka cancanta. Ingantattun ababen more rayuwa a ƙasar da kuma samun ɗimbin majinyata sun haɓaka ƙoƙarin bincike da ci gaba. Tare da alƙawarin haɓaka wannan sabuwar fasahar, Sin tana ba da gudummawa sosai ga yanayin aikin rigakafi na cutar kansa a duniya, yana haɓaka zaɓuɓɓukan jiyya ga marasa lafiya a duk faɗin ƙasar.

Duba cikakkun bayanai

CAR T-Cell far a cikin Isra'ila

A cikin Isra'ila, CAR T-cell far ya fito a matsayin hanya mai canzawa a cikin yaki da ciwon daji. Bangaren kula da lafiya na kasar, wanda ya shahara wajen bincike da kirkire-kirkire a duniya, ya samu gagarumin ci gaba wajen bunkasawa da aiwatar da magungunan CAR T-cell ga majinyata da ke fama da cutar jini da kuma ciwace-ciwace. Manyan cibiyoyin kiwon lafiya da kamfanonin fasahar kere-kere a Isra'ila suna da hannu sosai a cikin gwaje-gwaje na asibiti da ayyukan bincike, suna tura iyakoki na CAR T-cell far. Yanayin haɗin gwiwa na Isra'ila da fasahohin zamani sun sanya ta a matsayin ɗan wasa na duniya don haɓaka rigakafin rigakafi, yana ba da sabbin hanyoyin jiyya da bege ga masu cutar kansa, na gida da na duniya.

Duba cikakkun bayanai

CAR T-Cell far a Singapore

CAR T-cell far ya yi tasiri sosai a cikin yanayin kiwon lafiya na Singapore, yana ba da kyakkyawar hanya don maganin ciwon daji. Ingantattun kayayyakin aikin likita na ƙasar da iyawar bincike sun ba da damar haɓakawa da aikace-aikacen wannan babban maganin rigakafi. Marasa lafiya a Singapore yanzu suna da damar yin amfani da CAR T-cell far don cututtukan daji daban-daban na jini, wanda ke nuna canjin canji a cikin kulawar oncology. Cibiyoyin kula da lafiya na gida suna da hannu sosai a cikin gwaje-gwaje na asibiti da haɗin gwiwa tare da masana na duniya, tabbatar da cewa marasa lafiya sun sami magani na duniya. Tare da sadaukar da kai ga ƙididdigewa da kulawa da haƙuri, Singapore tana taka muhimmiyar rawa wajen haɓaka maganin CAR T-cell, yana ba da sabon bege ga masu ciwon daji a yankin da kuma bayan.

Duba cikakkun bayanai

CancerFax: Ƙarfafa Rayuwa, Canza Tafiya

"Namu hangen nesa shine jagoranci hanya wajen kawo sauyi wajen magance cutar kansa, da tabbatar da samun damar kowane mutum na keɓantacce, cikakke, da kulawar jin kai. Ta hanyar sabbin hanyoyin warwarewa da sadaukar da kai, muna ƙoƙari don kawar da shinge, samar da bege, da ba da gudummawa ga duniyar da cutar kansa ba kawai magani ba ce amma ana iya shawo kanta."

Ofishin Jakadancin Sirri

"Ta hanyar sabbin hanyoyin warwarewa da sadaukar da kai, muna ƙoƙari don kawar da shinge, samar da bege, da ba da gudummawa ga duniyar da cutar kansa ba kawai magani ba ce amma ana iya yin nasara."

 
Mun himmatu ga:
  • 1. Hanyoyi Na Musamman: Daidaita zaɓuɓɓukan jiyya zuwa buƙatun kowane mai haƙuri.
  • 2. Gidan yanar gizo: Gina hanyar sadarwa ta duniya na shahararrun masana ilimin likitanci, cibiyoyin jiyya masu yanke shawara, da sabis na tallafi.
  • 3. Ƙarfafa Ta hanyar Ilimi: Samar da cikakkun bayanai, na yau da kullun.
  • 4. Taimakon Tausayi: Bayar da tallafi na tunani da aiki.
  • 5. Ƙirƙira da Bincike: Haɗin kai tare da manyan cibiyoyin bincike.
  • 6. Shawara da Fadakarwa: Shawarwari don ingantattun manufofin kula da cutar kansa.
  • 7. Kyakkyawan Da'a: Ɗaukaka mafi girman ƙa'idodin ɗa'a.

Duba cikakkun bayanai

shedu

Me marasa lafiya suka ce game da mu?

Muna son masu amfani da mu saboda suna son mu. Duba wasu soyayyar da suka aiko mana

"Na rubuta wannan shaidar ne don in nuna godiyata ga irin canjin rayuwa da na samu tare da ƙungiyar CancerFax, wanda ya gabatar da ni ga CAR T-cell far a kasar Sin. Tafiyata na fama da ciwon daji ta ɗauki wani yanayi mai ban sha'awa lokacin da aka gabatar da ni ga wannan jiyya mai ban sha'awa, kuma ba ta kasance mai ban mamaki ba. Kafin CAR T-cell far, Na gaji da jiyya na al'ada ba tare da nasara sosai ba. Halina ya yi muni, kuma bege yana dusashewa. Koyaya, shawarar da na yanke na yin maganin CAR T-cell therapy a China ya zama abin juyi. Matsayin kulawa da ƙwarewa da na samu ya kasance na musamman. Tawagar likitocin ba wai ƙwararru ba ce kawai amma kuma tana da tausayi sosai, tana ba ni tallafi da tabbacin da nake buƙata a wannan lokacin ƙalubale."

Bjorn Simenson

Multiple Myeloma Survivor, Norway

Tambayoyin da ake yawan yi.

Nemo a ƙasa amsoshin tambayoyin da aka fi sani da marasa lafiya game da maganin ciwon daji.

Wadanne zaɓuɓɓukan jiyya na ci gaba da ake samu don ciwon daji?

Zaɓuɓɓukan maganin ciwon daji na ci gaba sun haɗa da:

  • Immunotherapy: Wannan maganin yana amfani da tsarin garkuwar jiki don yaƙar ƙwayoyin cutar kansa. Yana iya yin tasiri sosai a wasu cututtukan daji ta hanyar haɓaka martanin rigakafi daga ƙwayoyin cutar kansa.

  • Maganin Niyya: Wannan ya haɗa da magunguna waɗanda ke yin niyya musamman ga maye gurbi ko rashin daidaituwa a cikin ƙwayoyin cutar kansa, yana rage lalacewar ƙwayoyin lafiya.

  • Daidaitaccen Magani: Ta hanyar nazarin fasalin halittar majiyyaci da halayen ƙari, likitoci za su iya tsara jiyya don takamaiman nau'in ciwon daji, wanda zai haifar da sakamako mai inganci.

  • CAR T-cell Far: Wannan sabuwar hanyar farfadowa ta ƙunshi gyare-gyaren kwayoyin halitta na T-cell na majiyyaci don ganewa da kuma kai hari ga kwayoyin cutar kansa, musamman a cikin ciwon daji na jini kamar cutar sankarar bargo, myeloma mai yawa, da lymphoma.

Maganin ciwon daji na ci gaba yana ba da fa'idodi da yawa:

  • Ingantattun Tasiri: Magungunan da aka yi niyya da maganin rigakafi sau da yawa sun fi tasiri kuma daidai, yana haifar da sakamako mafi kyau da ƙananan sakamako masu illa.

  • Hanyar Keɓaɓɓen: Yawancin jiyya na ci gaba ana keɓance su da bayanan kwayoyin halittar mutum da na kwayoyin halitta, suna haɓaka tasiri yayin da ake rage jiyya maras buƙata.

  • Rage Tasirin Side: Idan aka kwatanta da chemotherapy na gargajiya da radiation, ci-gaba hanyoyin kwantar da hankali na iya samun ƙarancin sakamako masu illa, inganta ingancin rayuwa yayin jiyya.

  • Ƙarfafa Yawan Rayuwa: Yawancin jiyya na ci gaba sun nuna don inganta ƙimar rayuwa da sakamako na dogon lokaci, musamman a lokuta na ci gaba ko ciwon daji.

Samun dama ga ci gaban jiyya na kansa ya ƙunshi matakai da yawa:

  • CancerFax: Ku aiko mana da rahoton ku na likitanci ta imel ko WhatsApp kuma ƙungiyar likitocinmu za ta jagorance ku da mafi kyawun zaɓin maganin cutar kansa.

  • Shawarwari tare da Oncologist: Ya kamata marasa lafiya su tattauna zaɓuɓɓukan jiyya na ci gaba tare da likitan ilimin likitancin su, wanda zai iya ba da bayani game da hanyoyin kwantar da hankali da kuma dacewa ga lokuta ɗaya.

  • Gwaji na Clinical: Kasancewa cikin gwaje-gwajen asibiti na iya ba da damar yin amfani da jiyya na yanke-yanke waɗanda har yanzu ba su da yawa.

  • Rufin Inshorar Lafiya: Ya kamata marasa lafiya su duba tare da mai ba da inshorar lafiyar su don fahimtar ɗaukar hoto don ci gaban jiyya da haɗin kai.

  • Komawa zuwa Cibiyoyin Musamman: Magana zuwa cibiyoyin ciwon daji na musamman ko asibitocin da aka sani don ci gaba da kula da ciwon daji na iya tabbatar da samun dama ga zaɓuɓɓukan magani da yawa.

  • Ƙungiyoyin Shawarwari na Mara lafiya: Waɗannan ƙungiyoyi za su iya ba da albarkatu, tallafi, da bayanai kan samun ci-gaban jiyya da kewaya tsarin kiwon lafiya yadda ya kamata. Kasance tare da rukuninmu na Facebook, Kawar da cutar daji.

Faxar Cancer yana da alaƙa da wasu manyan asibitocin ciwon daji na duniya da na Amurka. Duba jerin asibitocinmu na sama kuma zaɓi wanda ya dace da bukatun ku. Ƙungiyar mu ta likitanci kuma za ta iya taimaka muku zaɓi wanda ya dace da buƙatunku da buƙatunku. Duba jerin abubuwan mafi kyawun asibitocin ciwon daji a Amurka. .

Kuna buƙatar samar da bayanan likita masu zuwa:
  • 1. Likitan taƙaitaccen bayani
  • 2. Sabon PET CT scan
  • 3. Sabbin rahotannin jini
  • 4. Rahoton Biopsy
  • 5. Ciwon kasusuwan kasusuwa (Ga masu ciwon daji na jini)
  • 6. Duk binciken da aka yi a cikin tsarin DICOM
Baya ga wannan kuna buƙatar sanya hannu kan takardar izinin haƙuri ta hanyar CancerFax.
Shawarar ciwon daji ta kan layi tana nufin tsarin samun shawarwarin likita, ganewar asali, da shawarwarin jiyya don al'amurran da suka shafi ciwon daji ta hanyar dandamali. Yana ba wa marasa lafiya damar sadarwa ta nesa tare da likitocin oncologists da sauran ƙwararrun kiwon lafiya ta hanyar kiran bidiyo da fasahar telemedicine. Shawarwarin kan layi suna ba da dacewa da samun dama, musamman ga waɗanda ke da al'amuran motsi ko waɗanda ke zaune a yankuna masu nisa.
Yin amfani da fasahar telemedicine, shawarwarin kansar kan layi suna haɗa marasa lafiya da ƙwararrun kiwon lafiya daga nesa. Marasa lafiya za su iya tattauna abubuwan da suka shafi ciwon daji, raba bayanan likitanci, da samun shawarar kwararru ta hanyar amintattun kiran bidiyo ko dandamalin tarho. Likitoci na iya bincika bayanan da aka bayar daga nesa kuma su ba da ganewar asali, shawarwarin jiyya, da tallafi mai gudana. Idan akwai buƙata, ƙwararrun kuma za su iya haɗawa da likitocin gida don tsara tsarin jiyya wanda ya fi dacewa da majiyyaci.
Ee, kuna samun takardar sayan magani da cikakken rahoto / ka'ida kan tsarin jiyya da ake buƙata.
Ba kwa buƙatar kowane kayan aiki don tuntuɓar kan layi; kawai kuna buƙatar shawarwarin ilimin cututtuka da kuma rubutaccen rahoto. Don shawarwarin bidiyo da wayar tarho, kuna buƙatar wayar mai kaifin baki tare da ingantaccen saurin intanet.

CAR T-cell far, ko chimeric antigen receptor T-cell far, wata sabuwar dabara ce ta immunotherapy. Ya haɗa da tattara ƙwayoyin T na majiyyaci, canza su ta hanyar gado don ci gaban ƙwayoyin cutar kansa yadda ya kamata, sa'an nan kuma sanya waɗannan sel ɗin da aka gyara su koma cikin jikin majiyyaci. Kwayoyin CAR T na iya ganewa kuma su kai hari kan ƙwayoyin kansa da daidaito. Bincika cikakkun bayanai akan CAR T-Cell far. .

Cancantar maganin CAR T-cell ya dogara da abubuwa daban-daban, gami da nau'in ciwon daji, matakin sa, da lafiyar majiyyaci gabaɗaya. Yawanci, ana la'akari da CAR T-cell far ga marasa lafiya da wasu nau'o'in ciwon daji na jini da suka koma baya, kamar cutar sankarar bargo ko lymphoma, waɗanda ba su amsa daidaitattun jiyya ba. Kwararren likitan ku zai tantance takamaiman shari'ar ku don tantance cancanta.
CAR T-cell far na iya samun sakamako masu illa, ciki har da ciwon saki na cytokine (CRS) da kuma illolin neurologic. CRS na iya haifar da zazzaɓi, alamu masu kama da mura, kuma, a lokuta masu tsanani, rashin aikin gaɓoɓin jiki. Abubuwan da ke haifar da ciwon jijiyoyi na iya haɗawa da rudani ko tashin hankali. Ma'aikatan kiwon lafiya suna sa ido sosai da sarrafa waɗannan illolin. Yana da mahimmanci don tattauna haɗarin haɗari da fa'idodi tare da ƙungiyar likitan ku.
Gwajin asibiti wani binciken bincike ne da aka tsara don gwada sabbin jiyya ko tsoma baki don ciwon daji. Ta hanyar shiga, ƙila za ku sami damar yin amfani da manyan hanyoyin warkewa waɗanda za su iya yin tasiri fiye da daidaitattun jiyya. Gwaje-gwaje na asibiti kuma suna ba da gudummawa ga haɓaka ilimin likitanci da haɓaka kula da ciwon daji na gaba.
Kuna iya farawa ta hanyar tattauna zaɓuɓɓukan gwaji na asibiti tare da likitan ku ko mai ba da lafiya. Suna iya ba da shawarar gwaji bisa takamaiman nau'in ciwon daji, mataki, da tarihin likita. Bugu da ƙari, gidajen yanar gizo kamar ClinicalTrials.gov da ƙungiyoyin bayar da shawarwari na haƙuri galibi suna ba da bayanan bayanai na gwaji masu gudana.
Amfanin na iya haɗawa da samun dama ga sabbin jiyya, kula da lafiya na kusa, da yuwuwar ingantattun sakamako. Hatsari na iya bambanta amma yana iya haɗawa da illa daga jiyya na gwaji ko damar cewa sabon magani baya aiki da daidaitaccen kulawa. Yana da mahimmanci a tattauna duka haɗari da fa'idodi tare da ƙungiyar kula da lafiyar ku kafin yanke shawara.
Ba duk gwaje-gwaje na asibiti ne ke amfani da placebos ba, kuma da yawa sun haɗa da kwatanta maganin gwajin zuwa matsayin kulawa na yanzu. Idan an yi amfani da placebo, ana sanar da mahalarta tukuna, kuma ƙa'idodin ɗabi'a sun tabbatar da cewa ba a hana kowa magani ba. Ƙungiyar kula da lafiyar ku za ta yi bayanin ƙirar gwaji da ko placebo yana da hannu.
Ana gudanar da gwaje-gwaje na asibiti tare da mai da hankali kan lafiyar haƙuri. Kwamitocin da'a da ƙungiyoyi masu tsari suna sa ido a kansu tare da aiwatar da tsauraran ka'idoji. Za a sanar da ku game da haɗarin haɗari da kuma kula da ku a duk lokacin gwaji. Kuna iya janyewa daga gwaji a kowane lokaci idan kuna da damuwa game da aminci ko wasu batutuwa.
Yawanci, mai ɗaukar nauyin gwaji na asibiti yana da alhakin biyan kuɗin gwajin gwajin gwaji da gwaje-gwaje masu alaƙa. Koyaya, ƙila har yanzu kuna da alhakin daidaitattun kuɗaɗen aikin likita waɗanda basu da alaƙa da gwaji, kamar ziyarar likita na yau da kullun ko jiyya mara gwaji. Yana da mahimmanci a tattauna al'amuran kuɗi tare da mai gudanar da gwaji da mai ba da inshora don fahimtar abin da aka rufe da duk wani yuwuwar kashe kuɗi daga aljihu. Yawancin tsare-tsaren inshora yanzu suna rufe farashin yau da kullun na shiga gwaji na asibiti.
CAR T-cell far yawanci magani ne na lokaci ɗaya. Koyaya, wasu marasa lafiya na iya buƙatar ƙarin jiko ko wasu jiyya idan cutar kansa ta sake dawowa ko kuma idan akwai buƙatar kulawa ta dogon lokaci. Za a keɓance shirin ku na jiyya ga takamaiman yanayin ku.
Bayan CAR T-cell far, za a sa ido sosai don samun sakamako masu illa da kuma tantance tasirin maganin. Yawan nasara na iya bambanta dangane da nau'i da matakin ciwon daji. CAR T-cell far ya nuna sakamako mai ban sha'awa a cikin wasu marasa lafiya da suka sake dawowa ko ciwon daji na jini, wanda ke haifar da cikakkiyar gafara. Koyaya, martanin mutum ɗaya na iya bambanta, kuma yana da mahimmanci a tattauna hasashen ku tare da ƙungiyar likitan ku.

Ee, wasu kamfanoni sun fara CAR T-Cell far a Indiya tare da taimakon vectors daga China da Malaysia. Koyaya, wannan maganin har yanzu yana ƙarƙashin gwaji na asibiti. Ana neman fom ɗin izinin haƙuri da shawarwarin likita kafin ku je waɗannan gwaje-gwajen.

Farashin CAR T-cell far ya bambanta daga ƙasa zuwa ƙasa. Anan ne kusan farashin a ƙasashe daban-daban. Amurka - $ 600,000-700,000 USD China - $ 60,000-90,000 USD Indiya - $ 60,000-90,000 USD Isra'ila - $ 85,000-100,000 USD Singapore - $ 700,000-750,000 SGD

A kasar Sin, an yarda da maganin CAR T-cell da farko kuma ana amfani da shi don maganin cututtukan jini, kamar su. lymphoma, cutar sankarar bargo, da myeloma.
Duk da yake akwai wasu gwaje-gwaje na asibiti da kuma ƙoƙarin bincike na binciken maganin CAR T-cell don ciwon ciwace-ciwace, ci gaba a wannan yanki ya kasance a hankali idan aka kwatanta da cututtukan jini.

Dangane da bayanan da ke akwai, CAR T-cell therapy don ƙwaƙƙwaran ciwace-ciwace suna da kashi 9% kawai na jimillar jimillar jimillar jimillar CAR T-cell da ake haɓakawa a China.

An kwatanta tasirin maganin antigen receptor T-cell (CAR-T) a kasar Sin da madadin jiyya ta hanyar gwaji da bincike da yawa na asibiti. Ya zuwa shekarar 2022, kasar Sin tana da adadi mafi girma na binciken asibiti na CAR-T fiye da Amurka, musamman a cikin cututtukan jini. Magungunan CAR-T guda biyu, axicabtagene ciloleucel (Yescarta) da relmacabtagene autoleucel (Carteyva), an amince da su a kasar Sin ta Hukumar Kula da Kayayyakin Kiwon Lafiya ta Kasa (NMPA). CAR-T far a kasar Sin ya nuna inganci a daban-daban na hematologic malignancies, ciki har da B-cell m lymphoblastic cutar sankarar bargo (ALL), lymphoma, da Multi myeloma (MM). Koyaya, ƙalubalen sun kasance, kamar tsadar tsada, tsarin samarwa mai ɗaukar lokaci, da abubuwan da suka shafi rigakafi. Don magance waɗannan batutuwa, masu bincike na kasar Sin suna haɓaka dabarun inganta fasahar CAR-T, ciki har da haɓaka samfuran allogen CAR-T da kuma amfani da madadin wuraren kashe kuɗi. A taƙaice, maganin CAR-T a kasar Sin ya nuna sakamako mai ban sha'awa a cikin cututtukan cututtukan jini, tare da adadi mai yawa na gwaji na asibiti idan aka kwatanta da Amurka. Duk da haka, ƙalubalen sun kasance, kuma ana buƙatar ƙarin bincike don inganta farfadowa da fadada amfani da shi zuwa ciwace-ciwacen ƙwayoyi.

Farashin CAR T-Cell a China ya bambanta tsakanin 45,000 USD da 90,000 USD. Kudin gabaɗaya ya dogara da zaɓin asibiti da adadin antigens da aka zaɓa. Kudin magungunan CAR-T da aka amince da su a kasar Sin gabaɗaya ya kai kusan yuan Sinawa 1,200,000 (CNY), wanda yayi daidai da kusan dalar Amurka 170,000. Farashin Cilta-Cel, FUCASO (NMPA-an yarda) don mahara myeloma ya bambanta tsakanin 250,000 da 300,000 USD. Tasirin farashi na CAR-T cell far a kasar Sin ya bambanta dangane da takamaiman magani da yanayin mai haƙuri.

Duk kana bukatar ka sani game da
nau'in ciwon daji daban-daban

Manyan Asibitocin Cancer

ESTD: 1941

Lambar gadaje: 1200

MD Anderson Cancer Center, Amurka

Cibiyar Ciwon daji ta MD Anderson wata kungiya ce da aka sani wacce ke jagorantar duniya kan maganin cutar kansa, bincike, da ilimi. An kafa shi a cikin 1941 kuma yana dogara ne a Houston, Texas. Ya dade yana jagorantar bincike da magani na ciwon daji. Ana kiran wurin don Monroe Dunaway Anderson, ɗan kasuwa mai arziƙi kuma mai ba da agaji wanda ke da ra'ayin gina cikakkiyar cibiyar ciwon daji wanda zai canza yadda ake fahimtar kansa da kuma bi da shi.

ESTD: 2001

Lambar gadaje: 380

Cibiyar Cancer ta Parkway, Singapore

Asibitocin Parkway suna jan hankalin marasa lafiya na duniya saboda manyan wuraren aikin likita da gwaninta. Asibitocin Parkway shine babban mai ba da kiwon lafiya masu zaman kansu a Asiya.

ESTD: 2003

Lambar gadaje: 400

Asibitin Gobroad na Beijing, China

Asibitin Gobroad Boren na birnin Beijing wani wurin kiwon lafiya ne mai zaman kansa wanda aka sadaukar don ci gaban fasahar likitanci, kulawa da jin kai, da gamsuwa da haƙuri, wanda ke ba da fifiko ga jin daɗin marasa lafiya fiye da komai. Muna haɗa tsarin ilimin ci-gaba, hanyoyin bincike da magani, horarwar likita mai ɗorewa, ilimin haƙuri, gudanarwar asibiti, da ra'ayin sabis daga ƙungiyar likitocin mafi girma a Amurka, Mayo Clinic.

Fara hira
Kuna buƙatar taimako tare da maganin ciwon daji?
Duba lambar
Hello,
Barka da zuwa CancerFax!

CancerFax shine mafi amintaccen mai gudanarwa na masu haƙuri na ƙasa da ƙasa yana aiki tare da manyan asibitocin cutar kansa a duniya kamar MD Anderson, Dana Farber, Asan, NCC Japan, Sheba, Cibiyar Ciwon daji ta Beijing da Apollo don kawo muku mafi kyawun hanyoyin warkewa da magunguna.

Bari mu san wadanne ayyuka kuke so ku amfana?

1) Maganin ciwon daji a Amurka, Japan, Isra'ila, Indiya, Koriya ko Singapore?
2) CAR T-Cell jiyya
3) rigakafin cutar daji
4) Shawarar bidiyo ta kan layi
5) Maganin Proton